MYC and head and neck squamous cell carcinoma: Mechanistically, the anticancer effects of MLN4924 on HNSCC cells were mediated by G2 phase cell cycle arrest and the ultimate induction of c‐Myc/Noxa axis‐dependent apoptosis (Figure 6).